16-46660193-T-TTTG
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_018206.6(VPS35):c.*278_*279insCAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0135 in 189,544 control chromosomes in the GnomAD database, including 120 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.016 ( 77 hom., cov: 29)
Exomes 𝑓: 0.0040 ( 43 hom. )
Consequence
VPS35
NM_018206.6 3_prime_UTR
NM_018206.6 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.351
Genes affected
VPS35 (HGNC:13487): (VPS35 retromer complex component) This gene belongs to a group of vacuolar protein sorting (VPS) genes. The encoded protein is a component of a large multimeric complex, termed the retromer complex, involved in retrograde transport of proteins from endosomes to the trans-Golgi network. The close structural similarity between the yeast and human proteins that make up this complex suggests a similarity in function. Expression studies in yeast and mammalian cells indicate that this protein interacts directly with VPS35, which serves as the core of the retromer complex. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0164 (2373/144352) while in subpopulation NFE AF= 0.0244 (1608/65862). AF 95% confidence interval is 0.0234. There are 77 homozygotes in gnomad4. There are 1107 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 2373 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS35 | NM_018206.6 | c.*278_*279insCAA | 3_prime_UTR_variant | 17/17 | ENST00000299138.12 | NP_060676.2 | ||
VPS35 | XM_005256045.4 | c.*278_*279insCAA | 3_prime_UTR_variant | 15/15 | XP_005256102.1 | |||
VPS35 | XM_011523227.4 | c.*278_*279insCAA | 3_prime_UTR_variant | 17/17 | XP_011521529.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS35 | ENST00000299138.12 | c.*278_*279insCAA | 3_prime_UTR_variant | 17/17 | 1 | NM_018206.6 | ENSP00000299138 | P1 | ||
VPS35 | ENST00000568784.6 | c.*3339_*3340insCAA | 3_prime_UTR_variant, NMD_transcript_variant | 17/17 | 1 | ENSP00000456274 | ||||
VPS35 | ENST00000647959.1 | c.*2732_*2733insCAA | 3_prime_UTR_variant, NMD_transcript_variant | 18/18 | ENSP00000497702 |
Frequencies
GnomAD3 genomes AF: 0.0165 AC: 2375AN: 144254Hom.: 77 Cov.: 29
GnomAD3 genomes
AF:
AC:
2375
AN:
144254
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00398 AC: 180AN: 45192Hom.: 43 Cov.: 0 AF XY: 0.00298 AC XY: 69AN XY: 23180
GnomAD4 exome
AF:
AC:
180
AN:
45192
Hom.:
Cov.:
0
AF XY:
AC XY:
69
AN XY:
23180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0164 AC: 2373AN: 144352Hom.: 77 Cov.: 29 AF XY: 0.0158 AC XY: 1107AN XY: 70086
GnomAD4 genome
AF:
AC:
2373
AN:
144352
Hom.:
Cov.:
29
AF XY:
AC XY:
1107
AN XY:
70086
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Parkinson Disease, Dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at